CLINICAL_TRIALS ClinicalTrials.gov record update

First-in-Human, Dose Finding, Open Label Phase 1A-1B Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03199586
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:34.719953+00:00
Published At: 2025-07-20T00:00:00+00:00
Record Updated At: 2025-07-20
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Breast Cancer", "Pancreas Cancer", "Prostate Cancer", "Lung Cancer", "Colon Cancer", "Esophagus Cancer", "Liver Cancer", "Ovary Cancer", "Advanced or Metastatic Treatment-refractory Solid Tumor Malignancies"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-07-20"
protocolSection.identificationModule.nctId: "NCT03199586"
protocolSection.identificationModule.officialTitle: "First-in-Human, Dose Finding, Open Label Phase 1A-1B Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.